[1]
2025. Non-HDL-C and CRP: A Dual Approach to Unmask Hidden Cardiovascular Risk in Type 2 Diabetic Patients. Attahadi Medical Journal. (Jul. 2025), 211–215. DOI:https://doi.org/10.69667/amj.25304.